Skip to main content
logo
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
24.01
-0.01 (-0.04%)
Oct 19, 2026, 1:21 PM EDT - Market open

Adaptive Biotechnologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3,8322,4798857091,0933,960
Market Cap Growth
47.07%180.23%24.72%-35.07%-72.41%-51.03%
Enterprise Value
3,8712,4768425697983,441
Last Close Price
24.0216.246.004.907.6428.06

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
12.468.954.944.175.9025.66
PB Ratio
26.7311.024.372.302.356.56
P/TBV Ratio
166.4625.2711.023.853.238.31

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
12.588.944.703.344.3122.29

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
2.730.941.100.740.500.19
Net Debt / Equity Ratio
0.26-0.13-0.16-0.38-0.57-0.76
Net Debt / EBITDA Ratio
-1.820.760.250.651.482.35
Net Debt / FCF Ratio
-1.610.610.340.701.321.80
Asset Turnover
0.540.530.300.220.210.15
Inventory Turnover
17.3018.0915.3013.6811.8411.50
Quick Ratio
4.513.102.714.384.913.27
Current Ratio
4.803.342.894.665.123.54
Return on Equity (ROE)
-38.76%-27.82%-62.49%-58.34%-37.52%-30.77%
Return on Assets (ROA)
-4.12%-6.79%-16.18%-16.60%-14.06%-12.81%
Return on Capital Employed (ROCE)
-6.80%-13.50%-35.20%-35.20%-26.80%-25.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.66%-2.40%-18.03%-31.75%-18.32%-5.23%
FCF Yield
-0.63%-1.97%-11.18%-23.54%-18.33%-6.43%
Buyback Yield / Dilution
-4.11%-3.14%-1.88%-1.31%-1.54%-6.96%
SEC Filings: 10-K · 10-Q